Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aeva Announces First Strategic Customers for High-Precision Industrial Automation Sensors
-
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
-
Dutch Bros® to hold annual Drink One for Dane celebration
-
Barnes Aerospace Appoints George Whittier as CEO
-
Chuck E. Cheese Debuts Exclusive New Dippin’ Dots® Flavor: ‘Chuck E.'s Cookie Crunch’
-
monday.com Announces First Quarter 2025 Results
-
Rural King Opens New Warren Store, Bringing Farm and Home Essentials to the Region
-
Dentalcorp Reports First Quarter 2025 Results
-
BOARDWALKTECH ANNOUNCES STRATEGIC PARTNERSHIP WITH ZIDEAS CONSULTING AND APPOINTMENT OF JAY CHAKRABORTY TO ADVISORY BOARD
-
Phillips 66 to Host Annual Meeting of Shareholders
-
Essential Utilities Reports Strong First Quarter 2025 Results, 2025 Guidance and Long-Term Targets Affirmed
-
Amid Tariff Uncertainty, Re:Mind Launches as a Decision-Making Toolkit for a Volatile World
-
D-Wave CEO Dr. Alan Baratz Discusses Company’s Technical and Commercial Momentum on Fox Business’ The Claman Countdown
-
Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy
-
Kaspi.kz 1Q 2025 Financial Results
-
AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
-
Tiziana Life Sciences Announces Purchase of Shares by Chairman
-
Viasat's Arctic Broadband Dedicated Coverage Advances as Payloads Enter Service Onboard Space Norway’s Arctic Satellite Broadband Mission Spacecraft
-
EnviroGold Global Consolidates Process Development Technology and Strengthens IP Portfolio with New Patent Filing
-
Beamr Issues Q1-2025 CEO Letter to Shareholders: Experiencing Rising Demand for Our Technology Across Key Verticals
-
Macerich Reports First Quarter 2025 Results
-
Wag! Reports First Quarter 2025 Results
-
Blade Air Mobility Announces First Quarter 2025 Results
-
Enthusiast Gaming to Announce 1st Quarter 2025 Results on May 15th, 2025
-
Precore Gold Announces Nomination of Louis Gariepy to Its Board of Directors, Completion of the Arikepay Agreement and Granting of Stock Options
-
Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
-
Advantage Solutions Reports First Quarter 2025 Results
-
Chuck E. Cheese Debuts Exclusive New Dippin’ Dots® Flavor: ‘Chuck E.'s Cookie Crunch’
-
Sionna Therapeutics Reports First Quarter 2025 Financial Results
-
Harvard Bioscience Announces First Quarter 2025 Financial Results
-
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
-
OTC Markets Group Welcomes OMV AG to OTCQX
-
InStride Named a 2025 World’s Top EdTech Company by TIME and Statista
-
Kinaxis Supercharges BayWa r.e. Solar Trade’s Supply Chain with AI-Powered Orchestration
-
OTC Markets Group Welcomes Northisle Copper and Gold Inc. to OTCQX
-
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
-
Schouw & Co. share buy-back programme, week 19 2025
-
Signify share repurchase period update
-
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
-
Optima Health plc - Full Year Trading Update
-
Garmin expands avionics database solutions for South Pacific region
-
Invesco Ltd: Form 8.3 - QUALCOMM Inc; Public dealing disclosure
-
Invesco Ltd. Announces April 30, 2025 Assets Under Management
-
Church & Dwight to Acquire the Touchland® Brand for $700 million Plus Earn-out
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Arctech Showcased the Most Comprehensive Portfolios Based on "Tracker+" and "Green Power+" Platforms at Intersolar Europe 2025
-
US Technology Company Leverages No Offshoring Policy to Ease Tariff Challenges
-
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
-
Pharvaris to Host a Virtual R&D Call “Deucrictibant: Beyond HAE Type 1/2” on June 4

